Ayble Health Raises $16M for Virtual Digestive Care
The Series A funding will help Ayble Health scale its virtual clinic for digestive health conditions.
Ayble Health has closed a $16 million Series A round to advance its virtual digestive health clinic. The round was led by Neon, with backing from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx, and Accomplice. The participation of Cleveland Clinic Ventures suggests a bridge between digital health startups and established medical institutions.
The company focuses on delivering remote care for digestive conditions, an area that has seen growing demand for accessible treatment options. With this new capital, Ayble Health plans to broaden its services and reach more patients who might otherwise face barriers to specialty care.
While the announcement does not detail specific expansion plans, the investor mix—spanning venture firms and a major health system—points to confidence in the virtual care model. The funding also reflects a broader trend of digital health companies attracting significant investment for niche clinical areas.
More in Medicine & Biotech
Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Beacon Gene Therapy for Rare Vision Loss Succeeds in Pivotal Trial
A pivotal trial of Beacon Therapeutics' gene therapy for X-linked retinitis pigmentosa improved visual acuity, clearing the path toward an FDA submission.
Alkermes orexin agonist shows early promise for ADHD
Early-stage data suggest Alkermes' orexin agonist could expand the drug class beyond sleep disorders into ADHD.
Telix to Buy ITM for $1.65B, Challenging Novartis in Radiopharma
The acquisition gives Telix a late-stage pipeline and supply network that could compete with Novartis' Lutathera.